Back

Discussion - Biomarkers in Risk Assessment: Lipids and Beyond.

10 November 2019 (09:35 - 09:40)
Organised by:
Congress Presentation Part of: How to Assess Cardiovascular Risk in Clinical Practice? Cardiovascular Risk Assessment ESC Premium Access ESC Asia with APSC & AFC

5 More presentations in this session

Presentation thumbnail
Risk Scores: Advantages and Pitfalls.
Professor S. Gielen (Detmold, DE)
Slides Video
Presentation thumbnail
Discussion - Risk Scores: Advantages and Pitfalls
Presentation thumbnail
Biomarkers in Risk Assessment: Lipids and Beyond.
Doctor A. Fong (Kuching, MY)
Slides Video
Presentation thumbnail
Imaging – A Must or an Add-on in Risk Assessment?
Professor M. Marwan (Erlangen, DE)
Slides Video
Presentation thumbnail
Discussion - Imaging – A Must or an Add-on in Risk Assessment?

Access the full session

Session thumbnail
How to Assess Cardiovascular Risk in Clinical Practice?

The Event

Event poster

ESC Asia with APSC & AFC

10 November 2019 09:35 CET
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources